Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
Eur Arch Otorhinolaryngol ; 279(11): 5381-5387, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35731292

ABSTRACT

PURPOSE: Previous cancers can be observed in patients with nasopharyngeal carcinoma (NPC). However, whether prior cancer diagnosis affects survival outcomes remains unknown. This study aimed to explore the impact of prior cancer on the survival of patients with NPC. METHODS: We retrospectively collected data from 666 NPC patients between 2006 and 2018. The patients in this study were divided into those without prior cancer, with prior head and neck cancer, and prior non-head and neck cancer. The demographic data and survival of these groups were then analyzed. The independent prognostic factors for NPC were determined using multivariate Cox regression analysis. RESULTS: We identified 25 NPC patients with prior cancer in our case series, most of whom had a history of colorectal cancer. Patients with a history of cancer were older than those without a history of cancer (p = 0.001). In the subgroup analysis stratified by the timing of prior cancer, NPC patients with prior non-head and neck cancer within 24, 36, 60, and 120 months showed worse survival than patients without prior cancer (all p < 0.05). When stratified by cancer stage, stage III NPC patients with prior non-head and neck cancer showed worse survival than patients without prior cancer (p < 0.001). Prior cancer and diabetes can predict worse survival in patients with stage III NPC. CONCLUSION: This study demonstrated that prior cancer and diabetes are independent prognostic factors in patients with stage III NPC.


Subject(s)
Nasopharyngeal Neoplasms , Humans , Nasopharyngeal Carcinoma/pathology , Nasopharyngeal Neoplasms/pathology , Neoplasm Staging , Prognosis , Retrospective Studies
3.
Support Care Cancer ; 30(7): 5821-5830, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35357575

ABSTRACT

PURPOSE: Radiotherapy for nasopharyngeal carcinoma (NPC) may induce cerebrovascular diseases including ischemic stroke and transient ischemic attack (TIA), which can cause severe disability. However, information on the incidence and predictors of cerebrovascular diseases is scarce. This study aimed to estimate the incidence of cerebrovascular diseases following NPC, and attempts to ascertain the predictors of cerebrovascular diseases to facilitate early prevention. METHODS: We performed a retrospective cohort study on 655 NPC patients who received radiotherapy between 2006 and 2018 in a medical center. This study analyzed the incidence, clinical and imaging presentation of patients with cerebrovascular diseases. Cox proportional hazard model was used to identify risk factors associated with cerebrovascular diseases following radiotherapy. RESULTS: There were 14 patients who developed an ischemic stroke, and 3 patients developed a TIA after a mean follow-up of 5.8 years. Most ischemic events were from large-artery atherosclerosis (76.5%), and the most common symptom of ischemic stroke was unilateral limb weakness (57.1%). The cumulative incidence of ischemic stroke or TIA 15 years after radiotherapy was 9.1% (95% confidence interval [CI] = 4.7-17.2%). Multivariate Cox regression identified vertebral artery stenosis (HR: 18.341; 95% CI = 3.907-86.100; P < 0.001), atrial fibrillation (HR: 13.314; 95% CI = 1.306-135.764; P = 0.029), and hypertension (HR: 7.511; 95% CI = 1.472-38.320; P = 0.015) as independent predictors of ischemic stroke or TIA. CONCLUSION: Our study found that NPC patients with vertebral artery stenosis, atrial fibrillation, or hypertension carry a higher risk for ischemic stroke or TIA. Regular assessment of vertebral artery after radiotherapy was suggested.


Subject(s)
Atrial Fibrillation , Hypertension , Ischemic Attack, Transient , Ischemic Stroke , Nasopharyngeal Neoplasms , Stroke , Vertebrobasilar Insufficiency , Atrial Fibrillation/complications , Humans , Ischemic Attack, Transient/diagnosis , Ischemic Attack, Transient/epidemiology , Ischemic Attack, Transient/etiology , Nasopharyngeal Carcinoma , Nasopharyngeal Neoplasms/radiotherapy , Retrospective Studies , Risk Factors , Stroke/diagnosis , Stroke/epidemiology , Stroke/etiology , Vertebrobasilar Insufficiency/complications , Vertebrobasilar Insufficiency/etiology
4.
Oral Oncol ; 110: 104990, 2020 11.
Article in English | MEDLINE | ID: mdl-32932171

ABSTRACT

OBJECTIVES: Nasopharyngeal carcinoma (NPC) is a common cancer and is treated primarily by chemotherapy and radiotherapy. However, NPC with synchronous second primary cancer (SSPC) is very rare and its risk factors, treatment and prognosis remain unclear. In this study, we aimed to analyze patients with NPC and SSPC, and attempt to find potential predictors for these patients. MATERIALS AND METHODS: We retrospectively collected 681 patients with NPC from 2006 to 2018. Patients in this study were divided into two groups: those patients with SSPC and those without SSPC. We then analyzed the demographic data and survival of these two groups. Independent predictors of SSPC were determined by multivariate regression analysis. A comprehensive review of the literature was also performed. RESULTS: We identified 17 NPC patients with SSPC in our case series and 13 cases in the literatures, and the most common SSPC is lung (16.1%). In univariate analysis, NPC patients with SSPC had older age (P < 0.001) and higher serum lactate dehydrogenase (LDH) (P = 0.008), compared with those without SSPC. In multivariate analysis, old age (P = 0.001) and high serum LDH (P = 0.023) remained independent predictors of SSPC, and a predictive equation model was established. NPC patients with SSPC had a significantly lower 5-year disease-specific survival rate compared with patients without SSPC (34.0% vs. 77.6%, P < 0.001) CONCLUSION: This study demonstrated that pretreatment age and serum LDH were independent predictors for SSPC in NPC patients. These independent factors can be used for early detection, and better facilitate the design of more appropriate treatment by medical professionals.


Subject(s)
Lactate Dehydrogenases/blood , Nasopharyngeal Carcinoma/blood , Nasopharyngeal Neoplasms/blood , Neoplasms, Second Primary/diagnosis , Neoplasms, Second Primary/etiology , Adult , Age Factors , Aged , Aged, 80 and over , Biomarkers , Clinical Decision-Making , Combined Modality Therapy , Disease Management , Early Detection of Cancer , Endoscopy , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Multimodal Imaging/methods , Nasopharyngeal Carcinoma/diagnosis , Nasopharyngeal Carcinoma/therapy , Nasopharyngeal Neoplasms/diagnosis , Nasopharyngeal Neoplasms/therapy , Neoplasm Grading , Neoplasm Staging , Neoplasms, Second Primary/mortality , Neoplasms, Second Primary/therapy , Prognosis , Retrospective Studies , Young Adult
5.
In Vivo ; 33(6): 1893-1899, 2019.
Article in English | MEDLINE | ID: mdl-31662517

ABSTRACT

BACKGROUND/AIM: Olfactory dysfunction can be caused by stroke but the pathogenesis is still unclear. Previous studies have proved that olfactory dysfunction could be caused by microglia activation in the olfactory bulb and that middle cerebral artery occlusion (MCAO) may induce ipsilateral olfactory bulb microglia activation. This study aimed to explore the possible pathogenesis of ischemic stroke-induced olfactory dysfunction. MATERIALS AND METHODS: We used a rat model of MCAO to simulate ischemic stroke. Olfactory function tests were performed using buried food test. The mRNA expression of olfactory marker protein (OMP), microglia/macrophage activation, and proinflammatory mediators were measured using reverse transcription-quantitative polymerase chain reaction. RESULTS: Following MCAO, rats had poorer olfactory performance. In the olfactory bulb of the rats, the mRNA expression of OMP decreased and the mRNA expression of microglia/macrophage activation and proinflammatory mediators increased. CONCLUSION: Ischemic stroke causes microglia/macrophage activation and promotes neuroinflammation in the olfactory bulb, causing olfactory dysfunction.


Subject(s)
Cytokines/metabolism , Inflammation/metabolism , Macrophages/metabolism , Microglia/metabolism , Olfactory Bulb/metabolism , Stroke/metabolism , Animals , Disease Models, Animal , Female , Infarction, Middle Cerebral Artery/metabolism , Male , Olfactory Marker Protein/metabolism , RNA, Messenger/metabolism , Rats , Rats, Inbred WKY
SELECTION OF CITATIONS
SEARCH DETAIL
...